Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuo Zhong

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Pharmacology|August 14, 2023
Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammationJing Lu, Jie Gao, Jing Sun, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 27, 2025
Exploring PU.1 as a Therapeutic Target to Mitigate Oxidative Stress and Inflammation in Peritoneal Dialysis-Induced Peritoneal FibrosisShuo Zhong, Wenyan Su, Yunzhao Wang, et al.
Optics Express|August 13, 2025
Minimalist infrared computational imaging with double-sided diffractive single-lens systemYidi Zheng, Shuo Zhong, Baiping Lei, et al.
Clinical Kidney Journal|May 8, 2025
Obinutuzumab is effective for the treatment of rituximab-refractory PLA2R-associated membranous nephropathyWenyan Su, Jianyi Li, Jinzhao Men, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Pharmacology|August 14, 2023
Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammationJing Lu, Jie Gao, Jing Sun, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 27, 2025
Exploring PU.1 as a Therapeutic Target to Mitigate Oxidative Stress and Inflammation in Peritoneal Dialysis-Induced Peritoneal FibrosisShuo Zhong, Wenyan Su, Yunzhao Wang, et al.
Optics Express|August 13, 2025
Minimalist infrared computational imaging with double-sided diffractive single-lens systemYidi Zheng, Shuo Zhong, Baiping Lei, et al.
Clinical Kidney Journal|May 8, 2025
Obinutuzumab is effective for the treatment of rituximab-refractory PLA2R-associated membranous nephropathyWenyan Su, Jianyi Li, Jinzhao Men, et al.
Pageof 2